Growth Metrics

OptimizeRx (OPRX) Free Cash Flow (2016 - 2026)

OptimizeRx's Free Cash Flow history spans 16 years, with the latest figure at $7.1 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 2118.38% to $7.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.7 million, a 290.56% increase, with the full-year FY2025 number at $18.7 million, up 290.56% from a year prior.
  • Free Cash Flow hit $7.1 million in Q4 2025 for OptimizeRx, up from $3.1 million in the prior quarter.
  • Over the last five years, Free Cash Flow for OPRX hit a ceiling of $7.1 million in Q4 2025 and a floor of -$7.0 million in Q4 2023.
  • Historically, Free Cash Flow has averaged $1.3 million across 5 years, with a median of $1.5 million in 2021.
  • Biggest five-year swings in Free Cash Flow: crashed 949.35% in 2023 and later soared 2118.38% in 2025.
  • Tracing OPRX's Free Cash Flow over 5 years: stood at -$1.6 million in 2021, then soared by 265.3% to $2.7 million in 2022, then crashed by 357.34% to -$7.0 million in 2023, then soared by 104.61% to $321000.0 in 2024, then soared by 2118.38% to $7.1 million in 2025.
  • Business Quant data shows Free Cash Flow for OPRX at $7.1 million in Q4 2025, $3.1 million in Q3 2025, and $4.6 million in Q2 2025.